Bioharvest Sciences Inc

BioHarvest Sciences Inc. is a biotechnology company that has developed and patented a proprietary technology platform known as Botanical Synthesis. This process enables the industrial-scale production of plant-based small and complex molecules by growing specific plant cells in bioreactors, effectively isolating and maximizing the potency of active ingredients without the need to grow the actual plant. The technology produces consistent, clean, and non-GMO botanical compositions that are enhanced by science, offering a sustainable alternative to traditional agricultural methods for ingredient development.

The company operates through two primary business units: a direct-to-consumer nutraceutical division and a contract development and manufacturing organization (CDMO) services business. Its flagship product, VINIA, is a red grape cell-derived nutraceutical that has undergone successful clinical trials to support heart health and blood flow. Through its CDMO arm, BioHarvest partners with companies in the pharmaceutical, nutrition, and cosmetic industries to develop proprietary plant-based molecules for various applications. Listed on the Nasdaq Global Market under the ticker BHST, the company maintains research and manufacturing operations with a focus on delivering science-based therapeutic solutions for health and wellness.